17:25 EDT Crispr Therapeutics files automatic mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
- Vertex Pharmaceuticals (NASDAQ:VRTX) Slides despite Raising Revenue Guidance
- CRSP Earnings this Week: How Will it Perform?
- JMP Securities healthcare analysts hold an analyst/industry conference call
- CRISPR Therapeutics Nears 52-Week Low. Time to Buy?